全文获取类型
收费全文 | 3425篇 |
免费 | 214篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 73篇 |
儿科学 | 53篇 |
妇产科学 | 79篇 |
基础医学 | 443篇 |
口腔科学 | 33篇 |
临床医学 | 269篇 |
内科学 | 679篇 |
皮肤病学 | 34篇 |
神经病学 | 253篇 |
特种医学 | 166篇 |
外科学 | 578篇 |
综合类 | 59篇 |
一般理论 | 2篇 |
预防医学 | 219篇 |
眼科学 | 190篇 |
药学 | 282篇 |
中国医学 | 8篇 |
肿瘤学 | 222篇 |
出版年
2023年 | 19篇 |
2022年 | 33篇 |
2021年 | 70篇 |
2020年 | 32篇 |
2019年 | 59篇 |
2018年 | 71篇 |
2017年 | 44篇 |
2016年 | 56篇 |
2015年 | 70篇 |
2014年 | 89篇 |
2013年 | 152篇 |
2012年 | 185篇 |
2011年 | 199篇 |
2010年 | 149篇 |
2009年 | 111篇 |
2008年 | 168篇 |
2007年 | 154篇 |
2006年 | 157篇 |
2005年 | 155篇 |
2004年 | 138篇 |
2003年 | 125篇 |
2002年 | 146篇 |
2001年 | 68篇 |
2000年 | 89篇 |
1999年 | 79篇 |
1998年 | 37篇 |
1997年 | 24篇 |
1996年 | 31篇 |
1995年 | 22篇 |
1994年 | 36篇 |
1993年 | 25篇 |
1992年 | 65篇 |
1991年 | 71篇 |
1990年 | 59篇 |
1989年 | 56篇 |
1988年 | 65篇 |
1987年 | 68篇 |
1986年 | 34篇 |
1985年 | 37篇 |
1984年 | 32篇 |
1983年 | 19篇 |
1982年 | 32篇 |
1981年 | 19篇 |
1980年 | 23篇 |
1979年 | 27篇 |
1978年 | 20篇 |
1977年 | 18篇 |
1976年 | 19篇 |
1974年 | 16篇 |
1971年 | 14篇 |
排序方式: 共有3642条查询结果,搜索用时 78 毫秒
1.
2.
F Lofaso F Nicot M Lejaille L Falaize A Louis A Clement J-C Raphael D Orlikowski B Fauroux 《The European respiratory journal》2006,27(5):980-982
Sniff nasal inspiratory pressure (SNIP) measurement is a volitional noninvasive assessment of inspiratory muscle strength. A maximum of 10 sniffs is generally used. The purpose of the present study was to investigate whether the maximum SNIP improved after the tenth sniff. In total, 20 healthy volunteers and 305 patients with various neuromuscular and lung diseases were encouraged to perform 40 and 20 sniffs, respectively. The best SNIP among the first 10 sniffs was lower than the best SNIP among the next 10 sniffs in the healthy volunteers and patients. The SNIP improvement after the twentieth sniff was marginal. In conclusion, a learning effect persists after the tenth sniff. The current authors suggest using 10 additional sniffs when the best result of the first 10 sniffs is slightly below normal, or when sniff nasal inspiratory pressure is used to monitor a progressive decline in inspiratory muscle strength. 相似文献
3.
P F Plouin D L Clement H Boccalon J Dormandy I Durand-Zaleski G Fowkes L Norgren T Brown 《International angiology》2003,22(4):333-339
Atherosclerotic renal artery stenosis (ARAS) may cause hypertension, progressive renal failure, and recurrent pulmonary edema. It typically occurs in high risk patients with coexistent vascular disease elsewhere. Most patients with ARAS are likely to die from coronary heart disease or stroke before end-stage renal failure occurs. Recent controlled trials have shown that most patients undergoing angioplasty to treat renovascular hypertension still need antihypertensive agents 6 or 12 months after the procedure. Nevertheless, the number of antihypertensive agents required to control blood pressure adequately is lower following angioplasty than for medication alone. Trials assessing the value of revascularization for preserving renal function or preventing clinical events are only in the early recruitment phase. Revascularization should be undertaken in patients with ARAS and resistant hypertension or heart failure, and probably in those with rapidly deteriorating renal function or with an increase in plasma creatinine levels during angiotensin-converting enzyme inhibition. With or without revascularization, medical therapy using antihypertensive, hypolipidemic and antiplatelet agents is necessary in almost all cases. 相似文献
4.
J. M. Bourre M. Clement J. Chaudiere 《Molecular and chemical neuropathology / sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid》1987,7(2):91-97
In the brain of quaking and shiverer mutants, vitamin E content was normal when related to both wet weight and dry weight. When related to lipid extract, phosphorus, and polyunsaturated fatty acids, vitamin E was slightly increased only in the quaking mutant. In the sciatic nerve from trembler mutants, vitamin E was 134% of control values in the dry material, but normal in relation to wet weight. It was 260% in the lipid extract and 716% based on phosphorus. In relation to total fatty acids, there was a threefold increase in trembler mutants. Interestingly, it was increased approximately three times when related to 18∶2 n?6, 20∶4 n?6, and 20∶5 n?3, and seven times when related to 22∶6 n?3. The fact that the amount of vitamin E in fresh weight was normal, suggests that vitamin E plays a role in some nonmembrane material, such as the extracellular matrix or the basal lamina. 相似文献
5.
6.
7.
8.
In contrast to the systolic blood pressure at the posterior tibial artery, the evaluation of pressure at the digital artery of the foot before and after exercise in patients with peripheral arterial disease is not well known. Twenty three patients with peripheral vascular disease were examined. The systolic pressure was measured by means of an ultrasound velocity detector at the brachial and posterior tibial artery. Digital artery pressure was determined with photoplethysmography. Pressures were measured before and within 5 and 10 minutes after a treadmill test. Ankle and toe index was calculated. At rest the toe index is lower than the ankle index and after a treadmill test the decrease in toe index occurs in parallel to the ankle index. 相似文献
9.
10.
P. E. Wallemacq Raymond Reding Etienne M. Sokal Jean Ville de Goyet Stéphane Clement de Clety Véronique Van Leeuw Marc De Backer Jean-Bernard Otte 《Transplant international》1997,10(6):466-470
Pediatric liver transplant recipients constitute a population characterized by a particularly unpredictable and poor bioavailability
of cyclosporin (CyA). Even though several adult studies show that the new oral formulation of CyA, Neoral (NEO), produces
better bioavailability and blood level predictability, few data describe its pharmacokinetics in children. We performed a
complete analysis of the pharmacokinetics of NEO in ten small children after primary liver transplantation. Three pharmacokinetic
profiles were set up with data obtained from tests taken during i. v. administration of CyA, after the first oral NEO dose,
and after the last NEO dose before discharge from the hospital. The mean half-lives obtained were 8.1, 7.7, and 6.9 h, respectively,
and the bioavailabilities were 22 % and 21 % for the first and last NEO doses. A large interpatient variability was observed.
This was due, in part, to episodes of diarrhea that interfered with the pharmacokinetic evaluation and, in part, to the variability
of post-transplant hepatic function. There was a good correlation between CyA trough levels and their related AUCs for both
NEO profiles (r = 0.93 and r = 0.74, respectively). We conclude that, even though the pediatric OLT population remains more unpredictable than that of
adults, NEO has a relatively rapid half-life and a remarkably improved bioavailability.
Received: 29 November 1996 Received after revision: 10 April 1997 Accepted: 15 May 1997 相似文献